Stay updated on Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial

Sign up to get notified when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site revision displayed in the page footer changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-02T12:45:24.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.7%
    Check dated 2026-10-26T14:08:10.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2. The study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-19T13:59:26.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The website footer now identifies the site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-12T14:44:49.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry (v3.7.0) and removes the previous revision (v3.6.6), updating the documented version history of the record.
    Difference
    0.1%
    Check dated 2026-09-21T21:49:26.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Record History now includes a new revision entry for v3.6.6 and drops the previous v3.6.5 from the list. This updates the page’s visible version history to reflect the latest revision entry for the study record.
    Difference
    0.1%
    Check dated 2026-08-31T18:09:02.000Z thumbnail image

Stay in the know with updates to Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.